Addition of daptomycin to levofloxacin increased the efficacy of levofloxacin monotherapy against a methicillin-susceptible Staphylococcus aureus strain in experimental meningitis and prevented development of resistance in vitro

J Med Microbiol. 2022 Feb;71(2). doi: 10.1099/jmm.0.001497.
No abstract available

Keywords: S. aureus; antibacterial resistance; daptomycin; experimental meningitis; levofloxacin.

MeSH terms

  • Animals
  • Anti-Bacterial Agents* / therapeutic use
  • Daptomycin* / therapeutic use
  • Levofloxacin* / therapeutic use
  • Meningitis* / drug therapy
  • Meningitis* / microbiology
  • Methicillin
  • Methicillin-Resistant Staphylococcus aureus
  • Microbial Sensitivity Tests
  • Staphylococcal Infections* / drug therapy
  • Staphylococcus aureus

Substances

  • Anti-Bacterial Agents
  • Levofloxacin
  • Daptomycin
  • Methicillin